BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02224781-completion@plaintrial.com
DTSTAMP:20260926T174440Z
DTSTART;VALUE=DATE:20260911
SUMMARY:Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or I
 pilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating 
 Patients With Stage III-IV BRAFV600 Melanoma — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT02224781
URL:https://plaintrial.com/trial/NCT02224781
END:VEVENT
END:VCALENDAR